A study evaluating pharmacodynamics and efficacy of Vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel disease
Latest Information Update: 26 May 2017
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Primary sclerosing cholangitis; Ulcerative colitis
- Focus Pharmacodynamics; Therapeutic Use
- 26 May 2017 New trial record
- 09 May 2017 Results presented at the Digestive Disease Week 2017